| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7279778 | Brain, Behavior, and Immunity | 2017 | 30 Pages |
Abstract
Higher baseline levels of IL-17 are selectively associated with greater symptomatic reduction in depressed patients treated with bupropion-SSRI combination.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Manish K. Jha, Abu Minhajuddin, Bharathi S. Gadad, Tracy L. Greer, Taryn L. Mayes, Madhukar H. Trivedi,